It’s time to take on your
enlarged prostate (BPH).

Discover a non-surgical, outpatient approach
through the Expander-2 Trial • Now enrolling

Millions of men struggle with urinary symptoms caused by an enlarged prostate, or BPH (benign prostatic hyperplasia). Nearly half of men in their 50’s and over 70% of men in their 60’s have BPH.1 As the prostate enlarges, it can cause a range of symptoms such as:

  • Frequent need to urinate both day and night
  • Weak or interrupted urinary stream
  • A sense that you cannot completely empty your bladder
  • Urgent feeling of needing to urinate

While there are medications and surgical treatments available for BPH, they do not work for everyone and can also cause unwanted side effects, including sexual dysfunction and urinary incontinence.

If you’re living with BPH and are interested in exploring non-surgical treatment options, you may qualify for the EXPANDER-2 Clinical Trial. The study is for the Urocross Expander System - an investigational, non-permanent implant designed to relieve BPH symptoms through a non-surgical procedure.

The Urocross™ Expander System

A non-permanent implant for relief of BPH symptoms, specifically designed to be removed

The prostate is about the size of a walnut, and is located at the neck of the bladder. For most men, starting around age 40 their prostate begins to grow. As the prostate enlarges it presses against the urethra, the tube that carries urine out of the body. This pressure blocks the natural flow of urine, causing uncomfortable symptoms and irritation.

The Urocross Implant is an investigational, non-permanent implant designed to relieve BPH symptoms through a non-surgical procedure. Urocross is a self-expanding implant that, once positioned, is designed to gently open and remodel the narrowed urethra to improve urinary flow. The Urocross procedure is performed using a flexible cystoscope commonly used for diagnostic evaluations and does not involve any incisions or tissue removal, allowing patients to return home the same day.

The Urocross Implant is left in place for six months to with the intent of remodeling the obstructing tissue, and then is removed through an outpatient procedure, leaving no foreign body behind.

What is the Expander-2 Trial?

The Urocross Expander System is currently available for investigational use at select sites in the US and Canada through the Expander-2 Clinical Trial. If you qualify and decide to join the study, you will receive the Urocross procedure and all study-related care at no cost. You will also be compensated for your time and travel to attend periodic visits at your study doctor’s office to evaluate your progress.

See If You Qualify

To learn more and see if you qualify for the Expander-2 Clinical Trial, please take the pre-screening questionnaire below:

1. Berry, et al., Journal of Urology 1984